PortfoliosLab logo
IOVA vs. MATW
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IOVA and MATW is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

IOVA vs. MATW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Iovance Biotherapeutics, Inc. (IOVA) and Matthews International Corporation (MATW). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

IOVA:

-0.94

MATW:

-0.56

Sortino Ratio

IOVA:

-1.92

MATW:

-0.64

Omega Ratio

IOVA:

0.75

MATW:

0.93

Calmar Ratio

IOVA:

-0.84

MATW:

-0.37

Martin Ratio

IOVA:

-1.90

MATW:

-1.31

Ulcer Index

IOVA:

43.51%

MATW:

19.93%

Daily Std Dev

IOVA:

87.24%

MATW:

47.72%

Max Drawdown

IOVA:

-99.37%

MATW:

-75.27%

Current Drawdown

IOVA:

-98.85%

MATW:

-66.74%

Fundamentals

Market Cap

IOVA:

$554.33M

MATW:

$641.57M

EPS

IOVA:

-$1.22

MATW:

-$2.55

PEG Ratio

IOVA:

0.00

MATW:

1.92

PS Ratio

IOVA:

2.61

MATW:

0.38

PB Ratio

IOVA:

0.72

MATW:

1.59

Total Revenue (TTM)

IOVA:

$212.68M

MATW:

$1.70B

Gross Profit (TTM)

IOVA:

$40.83M

MATW:

$518.98M

EBITDA (TTM)

IOVA:

-$365.16M

MATW:

$55.92M

Returns By Period

In the year-to-date period, IOVA achieves a -75.27% return, which is significantly lower than MATW's -23.61% return. Over the past 10 years, IOVA has underperformed MATW with an annualized return of -16.24%, while MATW has yielded a comparatively higher -6.41% annualized return.


IOVA

YTD

-75.27%

1M

-40.20%

6M

-78.29%

1Y

-82.13%

3Y*

-50.87%

5Y*

-45.27%

10Y*

-16.24%

MATW

YTD

-23.61%

1M

7.36%

6M

-10.07%

1Y

-26.36%

3Y*

-9.62%

5Y*

2.78%

10Y*

-6.41%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Iovance Biotherapeutics, Inc.

Risk-Adjusted Performance

IOVA vs. MATW — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IOVA
The Risk-Adjusted Performance Rank of IOVA is 33
Overall Rank
The Sharpe Ratio Rank of IOVA is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of IOVA is 22
Sortino Ratio Rank
The Omega Ratio Rank of IOVA is 33
Omega Ratio Rank
The Calmar Ratio Rank of IOVA is 44
Calmar Ratio Rank
The Martin Ratio Rank of IOVA is 11
Martin Ratio Rank

MATW
The Risk-Adjusted Performance Rank of MATW is 2020
Overall Rank
The Sharpe Ratio Rank of MATW is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of MATW is 1919
Sortino Ratio Rank
The Omega Ratio Rank of MATW is 2020
Omega Ratio Rank
The Calmar Ratio Rank of MATW is 2626
Calmar Ratio Rank
The Martin Ratio Rank of MATW is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IOVA vs. MATW - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Iovance Biotherapeutics, Inc. (IOVA) and Matthews International Corporation (MATW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current IOVA Sharpe Ratio is -0.94, which is lower than the MATW Sharpe Ratio of -0.56. The chart below compares the historical Sharpe Ratios of IOVA and MATW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

IOVA vs. MATW - Dividend Comparison

IOVA has not paid dividends to shareholders, while MATW's dividend yield for the trailing twelve months is around 4.78%.


TTM20242023202220212020201920182017201620152014
IOVA
Iovance Biotherapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MATW
Matthews International Corporation
4.78%3.50%2.54%2.92%2.36%2.87%2.12%1.90%1.33%0.81%1.01%0.95%

Drawdowns

IOVA vs. MATW - Drawdown Comparison

The maximum IOVA drawdown since its inception was -99.37%, which is greater than MATW's maximum drawdown of -75.27%. Use the drawdown chart below to compare losses from any high point for IOVA and MATW. For additional features, visit the drawdowns tool.


Loading data...

Volatility

IOVA vs. MATW - Volatility Comparison

Iovance Biotherapeutics, Inc. (IOVA) has a higher volatility of 64.97% compared to Matthews International Corporation (MATW) at 12.04%. This indicates that IOVA's price experiences larger fluctuations and is considered to be riskier than MATW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

IOVA vs. MATW - Financials Comparison

This section allows you to compare key financial metrics between Iovance Biotherapeutics, Inc. and Matthews International Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M20212022202320242025
49.32M
427.63M
(IOVA) Total Revenue
(MATW) Total Revenue
Values in USD except per share items